Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2021-11-29 $0.0003 $0.0003 $0.0001 $0.0001 110 323
2021-11-26 $0.0001 $0.0001 $0.0001 $0.0001 100
2021-11-24 $0.0001 $0.0001 $0.0001 $0.0001 5 000
2021-11-23 $0.0001 $0.0001 $0.0001 $0.0001 7 777
2021-11-22 $0.0001 $0.0001 $0.0001 $0.0001 557
2021-11-19 $0.0001 $0.0001 $0.0001 $0.0001 128 196
2021-11-18 $0.0001 $0.0001 $0.0001 $0.0001 1 386
2021-11-17 $0.0001 $0.0001 $0.0001 $0.0001 8 500
2021-11-16 $0.0001 $0.0001 $0.0001 $0.0001 10 506
2021-11-15 $0.0001 $0.0001 $0.0001 $0.0001 0
2021-11-12 $0.0001 $0.0001 $0.0001 $0.0001 43 400
2021-11-11 $0.0001 $0.0001 $0.0001 $0.0001 0
2021-11-10 $0.0001 $0.0001 $0.0001 $0.0001 0
2021-11-09 $0.0002 $0.0002 $0.0002 $0.0002 66 002
2021-11-08 $0.0001 $0.0002 $0.0001 $0.0002 66 002
2021-11-05 $0.000001 $0.000001 $0.000001 $0.000001 2 234
2021-11-04 $0.0001 $0.0001 $0.0001 $0.0001 2 500
2021-11-03 $0.0001 $0.0001 $0.0001 $0.0001 0
2021-11-02 $0.0001 $0.0001 $0.0001 $0.0001 0
2021-11-01 $0.0001 $0.0001 $0.0001 $0.0001 41 260
2021-10-29 $0.0001 $0.0001 $0.0001 $0.0001 41 260
2021-10-28 $0.000001 $0.000001 $0.000001 $0.000001 25
2021-10-27 $0.0008 $0.0008 $0.0008 $0.0008 90
2021-10-26 $0.0008 $0.0008 $0.0008 $0.0008 0
2021-10-25 $0.0008 $0.0008 $0.0008 $0.0008 4 670
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT